Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-11-07

Clinical Trial Update: Investigation of Flare and Remission in Subjects With Atopic Dermatitis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating flare and remission in subjects with atopic dermatitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: LEO Pharma | Conditions: Atopic Dermatitis | Phase 4 | Status: WITHDRAWN